SCHEMBL2163786

SCHEMBL2163786

CCC(=O)Oc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.38
VCAM1 P19320 8/20 0.38
LMNA P02545 2/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CA2 P00918 1/20 0.37
POLB P06746 1/20 0.37
TYR P14679 1/20 0.37
GLRA3 O75311 1/20 0.37
GLRB P48167 1/20 0.37
GAA P10253 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GLA P06280 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ALOX15 P16050 1/20 0.36
HMGCR P04035 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29669624 1.00 ACHE (0.38) ACHEVCAM1LMNARECQLSMN1; SMN2
SCHEMBL30488761 0.88 VCAM1 (0.40) ACHEVCAM1LMNARECQLALDH1A1
SCHEMBL11622245 0.88 VCAM1 (0.43) ACHEVCAM1LMNARECQLSMN1; SMN2
SCHEMBL31176236 0.85 HMGCR (0.35) VCAM1LMNARECQLALDH1A1GAA
SCHEMBL28794914 0.83 CA2 (0.40) VCAM1LMNASMN1; SMN2ALDH1A1CA2
SCHEMBL8832899 0.81 SMN1; SMN2 (0.38) LMNARECQLSMN1; SMN2ALDH1A1CA2
SCHEMBL28425957 0.80 ALOX5 (0.39) VCAM1GAAXBP1ATMNPSR1
SCHEMBL29367920 0.80 ALOX5 (0.39) VCAM1GAAXBP1ATMNPSR1
SCHEMBL526572 0.80 ALOX5 (0.39) VCAM1GAAXBP1ATMNPSR1
SCHEMBL28701034 0.80 ALOX5 (0.39) VCAM1GAAXBP1ATMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678116-B1 PREPARATION OF TETRAKIS [3-(E,5-DI-TERT-BUTYL-4-HYDROXY PHENYL) PROPIONYL OXYMETHYL] METHANE GREAT LAKES CHEMICAL EUROP (CH) 2012-10-03 EP claimed
US-20070208189-A1 Preparation of Tetrakis [3-(3,5-DI-Tert-Butyl-4-Hydroxy Phenyl) Propionyl Oxymethyl] Methane ADDIVANT USA, LLC 2007-09-06 US claimed
JP-2007509916-A 2007-04-19 JP claimed
EP-1678116-A1 PREPARATION OF TETRAKIS [3-(E,5-DI-TERT-BUTYL-4-HYDROXY PHENYL) PROPIONYL OXYMETHYL] METHANE Great Lakes Chemical (Europe) GmbH (CH) 2006-07-12 EP claimed
WO-2005042463-A1 PREPARATION OF TETRAKIS [3-(E,5-DI-TERT-BUTYL-4-HYDROXY PHENYL) PROPIONYL OXYMETHYL] METHANE GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) 2005-05-12 WO claimed
CN-114133722-B PC composite material and preparation method and application thereof 金发科技股份有限公司 2023-09-19 CN disclosed
CN-108495888-B Additive mixture for stabilizing polyols and polyurethanes 巴斯夫欧洲公司 2021-03-02 CN disclosed
CN-107793763-B High-temperature-resistant heat-conducting silicone grease and preparation method thereof 佛山市三水铠潮材料科技有限公司 2020-08-11 CN disclosed
EP-1678116-B1 PREPARATION OF TETRAKIS [3-(E,5-DI-TERT-BUTYL-4-HYDROXY PHENYL) PROPIONYL OXYMETHYL] METHANE GREAT LAKES CHEMICAL EUROP (CH) 2012-10-03 EP disclosed
US-7985871-B2 Preparation of tetrakis[3(3,5-di-tert-butyl-4-hydroxyphenyl)propionyl oxymethyl]methane CHEMTURA CORPORATION (US) 2011-07-26 US disclosed
US-20100036151-A1 PREPARATION OF TETRAKIS[3(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONYL OXYMETHYL]METHANE CHEMTURA CORPORATION (US) 2010-02-11 US disclosed
US-7601862-B2 Preparation of tetrakis [3-(3,5-di-tert-butyl-4-hydroxy phenyl) propionyl oxymethyl] methane GREAT LAKES CHEMICAL (EUROPE) GMBH (GB) 2009-10-13 US disclosed
US-20070208189-A1 Preparation of Tetrakis [3-(3,5-DI-Tert-Butyl-4-Hydroxy Phenyl) Propionyl Oxymethyl] Methane ADDIVANT USA, LLC 2007-09-06 US disclosed
EP-1678116-A1 PREPARATION OF TETRAKIS [3-(E,5-DI-TERT-BUTYL-4-HYDROXY PHENYL) PROPIONYL OXYMETHYL] METHANE Great Lakes Chemical (Europe) GmbH (CH) 2006-07-12 EP disclosed
WO-2005042463-A1 PREPARATION OF TETRAKIS [3-(E,5-DI-TERT-BUTYL-4-HYDROXY PHENYL) PROPIONYL OXYMETHYL] METHANE GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100036151-A1 PREPARATION OF TETRAKIS[3(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONYL OXYMETHYL]METHANE TERT, HPD, TBL3 ACHE 1550/4885VCAM1 4675/4885LMNA 3435/4885
US-20070208189-A1 Preparation of Tetrakis [3-(3,5-DI-Tert-Butyl-4-Hydroxy Phenyl) Propionyl Oxymethyl] Methane TERT, HPD, TBL3 ACHE 1602/4885VCAM1 4466/4885LMNA 3267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.